Rapid risk assessment: Emergence of resistance to ceftazidime-avibactam in carbapenem-resistant Enterobacteriaceae

risk assessment
Cite:
Citation Link

European Centre for Disease Prevention and Control. Emergence of resistance to ceftazidime-avibactam in carbapenem-resistant Enterobacteriaceae – 12 June 2018.  Stockholm; ECDC; 2018. 

Copy citation to clipboard

This risk assessment will discuss CAZ-AVI resistance in brief, review the recent literature reporting resistance of CRE to CAZ-AVI, and assess the risk for the EU/EEA countries. It will outline options for appropriate detection of resistance and the correct and timely implementation of IPC measures to prevent spread of these highly resistant organisms within healthcare settings and across borders.

Related content

Publication

Gonococcal antimicrobial susceptibility surveillance in Europe, 2016

surveillance report -

Publication

ECDC country visit to Belgium to discuss antimicrobial resistance issues

mission report -

News

Carbapenemase-producing (OXA-48) Klebsiella pneumoniae ST392 found in travellers previously hospitalised in Gran Canaria, Spain

news -

Publication

Rapid risk assessment: Carbapenemase-producing (OXA-48) Klebsiella pneumoniae ST392 in travellers previously hospitalised in Gran Canaria, Spain

risk assessment -

Publication

Antimicrobial resistance (EARS-Net) - Annual Epidemiological Report for 2014

surveillance report -